UP!

VICL $0.68

VICL target price
0.68
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2015-06-24 Set Price Target HC Wainwright Buy $2.50
2015-06-23 Downgrade Roth Capital Buy to Neutral $4.65 to $1.65
2015-06-12 Initiated Coverage HC Wainwright Buy $2.50
2015-06-02 Initiated Coverage Roth Capital Buy $4.65
2012-09-21 Initiated Canaccord Genuity Buy $7
2009-06-12 Initiated Thomas Weisel Overweight $5
2008-11-25 Initiated Noble Financial Buy $5
2015-06-24 Set Price Target HC Wainwright Buy $2.50
2015-06-23 Downgrade Roth Capital Buy to Neutral $4.65 to $1.65
2015-06-12 Initiated Coverage HC Wainwright Buy $2.50
2015-06-02 Initiated Coverage Roth Capital Buy $4.65
2012-09-21 Initiated Canaccord Genuity Buy $7

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In VICL 0 funds of 2213 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
SINGER JAMES R 9.79%  (8670000) VICL /
ARMISTICE CAPITAL, LLC 2.60%  (2300000) ALIM / VICL /
BILINSKY IGOR Senior VP, Corporate Dev\'t 0.22%  (193798) APHB / RXDX / VICL /
Broadfoot Jill Marie Sr Vice President, CFO, Sec 0.16%  (145649) VICL /
ROLLAND ALAIN P PHD Exec VP, Product Development 0.14%  (127583) VICL /
MERTON ROBERT C 0.11%  (95451) VICL /
SAMANT VIJAY B President & CEO 0.10%  (87420) APHB / RPTP / VICL /
MORROW GEORGE J 0.03%  (27347) ALGN / NBIX / OTIC / SWY / VICL /
Beleson Richard M 0.02%  (22078) VICL /
SHERWIN STEPHEN A 0.02%  (22003) BIIB / NBIX / RIGL / VICL / VSTM /
SMITH LAWRENCE RUSSELL VP, Vaccine Research 0.02%  (17696) VICL /
LYONS GARY A 0.02%  (14906) CYTX / KBIO / NBIX / PDLI / RIGL / TKAI / VICL /
DOUGLAS R GORDON 0.01%  (10828) VICL /
SHENK THOMAS E 0.01%  (10000) KDMN / VICL /
Ramos Anthony Alan Chief Accounting Officer 0.01%  (9674) VICL /
CAMPBELL ROBERT H 0.01%  (6000) VICL /